Alebund Pharmaceuticals Raises $54.5 Million in Series B+ Financing Round to Fuel Development of Renal Disease Treatment apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
In this episode of China Money Podcast, listen to all the news headlines in the China venture investment and tech sector for the week ending April 23.
We monitored 75 different startup, growth stage, and pre-IPO investment deals closing in the past 5 days totaling US$1.77 billion across China. Investors such as BioTrack Capital, Sherpa Venture Capital, IDG Capital, Lilly Asia Ventures, 3H Health Investment, HG Capital, Sequoia Capital China, Alwin Capital, and Kunlun Fund all made investments this week in a bunch of startups ranging from gene editing to building information modeling to online education to artificial intelligence to cross-border trade, and everything in between. This is the April 23, 2021 edition of the China Money Podcast where we update you on the news, data, and insights you need for making private equity and venture capital decisions in China.
Photo: Pixabay
April 22, 2021
Chinese genome editing startup EdiGene Inc has secured 400 million yuan ($61.7 million) in a Series B+ round of financing led by private equity (PE) firm Loyal Valley Capital to advance its pipeline into clinics and to scale up the business operation.
The Series B+ round roped in new investors BioTrack Capital and Sherpa Healthcare Partners, two China-focused, healthcare venture capital (VC) companies. The firm’s existing investors including IDG Capital, Lilly Asia Venture, 3H Health Investment, Huagai Capital, Sequoia Capital China, Alwin Capital, and Kunlun Capital re-upped in the deal.
Founded in 2015, EdiGene is a clinical-stage biotech company that focuses on leveraging genome editing technologies to accelerate drug discovery and to develop novel therapeutics for a broad range of genetic diseases and cancer. The startup has established its proprietary
Meituan plans to start unmanned delivery in Shanghai next year Xia Huaxia, chief scientist of Chinese group-buying service company Meituan, said that in . Alibaba, Amazon, Baidu, Beijing, IDG Capital, Lilly Asia Ventures, Meituan Dianping, Microsoft, Pacific, Sequoia, Sequoia Capital China, Shanghai, Suzhou, Today, United States